IL6 and Gliosis: A sublethal dose of LPS was shown to exacerbate depressive-like behavior, BBB disruption, and expression of interleukin-6 (IL-6) in brains of young APP23 transgenic mice vs. controls, although these mice did not yet have pre-existing plaques or gliosis [28].